These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31579041)

  • 21. Oncological Long-term Outcome After Whole-gland High-intensity Focused Ultrasound for Prostate Cancer-21-yr Follow-up.
    Bründl J; Osberghaus V; Zeman F; Breyer J; Ganzer R; Blana A; Gierth M; Denzinger S; Burger M; Rosenhammer B
    Eur Urol Focus; 2022 Jan; 8(1):134-140. PubMed ID: 33483288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
    Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
    Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage high-intensity focused ultrasound (S-HIFU) for recurrence after primary radiotherapy of prostate cancer.
    Long Depaquit T; Campagna J; Bastide C; Baboudjian M; Corral R; Uleri A; Toledano H
    Fr J Urol; 2024 Jun; 34(5):102633. PubMed ID: 38547931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.
    Dickinson L; Arya M; Afzal N; Cathcart P; Charman SC; Cornaby A; Hindley RG; Lewi H; McCartan N; Moore CM; Nathan S; Ogden C; Persad R; van der Meulen J; Weir S; Emberton M; Ahmed HU
    Eur Urol; 2016 Oct; 70(4):668-674. PubMed ID: 26951947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morbidity of focal therapy in the treatment of localized prostate cancer.
    Barret E; Ahallal Y; Sanchez-Salas R; Galiano M; Cosset JM; Validire P; Macek P; Durand M; Prapotnich D; Rozet F; Cathelineau X
    Eur Urol; 2013 Apr; 63(4):618-22. PubMed ID: 23265382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External validation of biochemical recurrence definition to predict oncologic outcomes following focal therapy for localized prostate cancer using high intensity focused ultrasound.
    Mattlet A; Limani K; Alexandre P; Hawaux E; Abou Zahr R; Aoun F; Diamand R
    Prostate; 2023 Dec; 83(16):1564-1571. PubMed ID: 37574824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.
    Ganzer R; Fritsche HM; Brandtner A; Bründl J; Koch D; Wieland WF; Blana A
    BJU Int; 2013 Aug; 112(3):322-9. PubMed ID: 23356910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer.
    Liu YY; Chiang PH
    Ann Surg Oncol; 2016 Jan; 23(1):328-34. PubMed ID: 26088651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure.
    Shah TT; Peters M; Kanthabalan A; McCartan N; Fatola Y; van der Voort van Zyp J; van Vulpen M; Freeman A; Moore CM; Arya M; Emberton M; Ahmed HU
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):311-6. PubMed ID: 27431499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal Therapy for Localized Prostate Cancer with Either High Intensity Focused Ultrasound or Cryoablation: A Single Institution Experience.
    Tourinho-Barbosa RR; Sanchez-Salas R; Claros OR; Collura-Merlier S; Bakavicius A; Carneiro A; Stabile A; Moschini M; Cathala N; Tobias-Machado M; Cathelineau X
    J Urol; 2020 Feb; 203(2):320-330. PubMed ID: 31437121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
    Apfelbeck M; Chaloupka M; Schlenker B; Stief CG; Clevert DA
    Clin Hemorheol Microcirc; 2019; 73(1):135-143. PubMed ID: 31561350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up.
    El Fegoun AB; Barret E; Prapotnich D; Soon S; Cathelineau X; Rozet F; Galiano M; Sanchez-Salas R; Vallancien G
    Int Braz J Urol; 2011; 37(2):213-9; discussion 220-2. PubMed ID: 21557838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes.
    Hostiou T; Gelet A; Chapelon JY; Rouvière O; Mège-Lechevalier F; Lafon C; Tonoli-Catez H; Badet L; Crouzet S
    BJU Int; 2019 Nov; 124(5):746-757. PubMed ID: 31148367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Exploratory Study of Dose Escalation
    Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
    J Endourol; 2020 Jun; 34(6):641-646. PubMed ID: 32253928
    [No Abstract]   [Full Text] [Related]  

  • 35. Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer.
    Stabile A; Orczyk C; Hosking-Jervis F; Giganti F; Arya M; Hindley RG; Dickinson L; Allen C; Punwani S; Jameson C; Freeman A; McCartan N; Montorsi F; Briganti A; Ahmed HU; Emberton M; Moore CM
    BJU Int; 2019 Sep; 124(3):431-440. PubMed ID: 30753756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer.
    van Velthoven R; Aoun F; Marcelis Q; Albisinni S; Zanaty M; Lemort M; Peltier A; Limani K
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):79-83. PubMed ID: 26597660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: A propensity score analysis.
    Capogrosso P; Barret E; Sanchez-Salas R; Nunes-Silva I; Rozet F; Galiano M; Ventimiglia E; Briganti A; Salonia A; Montorsi F; Cathelineau X
    Eur J Surg Oncol; 2018 Jan; 44(1):185-191. PubMed ID: 29223469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One].
    Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY
    Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
    Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
    BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.